Ask AI

Exploring the Expanded Clinical Utility of HER2 IHC Scoring in Metastatic Breast Cancer

  • Educate HCPs on the clinical significance of identifying patients with certain low levels of HER2 in metastatic breast cancer and raising awareness on the evolution of the HER2 spectrum
  • Highlight key considerations that impact HER2 IHC scoring and interpretation
  • Review guidance for pathologists to accurately report HER2 status

Program Content

Activities

Exploring the Expanded Clinical Utility of HER2 IHC Scoring in Metastatic Breast Cancer
Exploring the Expanded Clinical Utility of HER2 IHC Scoring in Metastatic Breast Cancer
Video
Congratulations: You achieved a completion on 04/09/2022

Released: August 20, 2025